Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary

被引:23
|
作者
Liu, Catherine [1 ]
Bayer, Arnold [3 ,6 ]
Cosgrove, Sara E. [7 ]
Daum, Robert S. [8 ]
Fridkin, Scott K. [9 ]
Gorwitz, Rachel J. [9 ]
Kaplan, Sheldon L. [10 ]
Karchmer, Adolf W. [11 ]
Levine, Donald P. [12 ,13 ]
Murray, Barbara E. [15 ,16 ]
Rybak, Michael J. [12 ,13 ,14 ]
Talan, David A. [4 ,5 ,6 ]
Chambers, Henry F. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94102 USA
[2] San Francisco Gen Hosp, Div Infect Dis, San Francisco, CA 94110 USA
[3] Harbor UCLA Med Ctr, Div Infect Dis, Torrance, CA 90509 USA
[4] Olive View UCLA Med Ctr, Div Emergency Med, Sylmar, CA 91342 USA
[5] Olive View UCLA Med Ctr, Div Infect Dis, Sylmar, CA 91342 USA
[6] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[7] Johns Hopkins Med Inst, Div Infect Dis, Baltimore, MD 21205 USA
[8] Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA
[9] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA
[10] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA
[11] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Infect Dis, Boston, MA 02215 USA
[12] Wayne State Univ, Dept Med, Div Infect Dis, Detroit Receiving Hosp, Detroit, MI 48202 USA
[13] Univ Hlth Ctr, Detroit, MI USA
[14] Wayne State Univ, Dept Pharm Practice, Detroit, MI USA
[15] Univ Texas Med Sch, Div Infect Dis, Houston, TX USA
[16] Univ Texas Med Sch, Ctr Study Emerging & Reemerging Pathogens, Houston, TX USA
关键词
NECROTIZING FASCIITIS; VENOUS THROMBOSIS; UNITED-STATES; MANIFESTATIONS; OSTEOMYELITIS; STRATEGIES; PNEUMONIA;
D O I
10.1093/cid/cir034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 50 条
  • [1] Guidelines of the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections: As Applied to Oral and Maxillofacial Clinical Practice
    Bhargava D.
    Deshpande A.
    Sreekumar K.
    Koneru G.
    Rastogi S.
    Journal of Maxillofacial and Oral Surgery, 2013, 12 (3) : 354 - 358
  • [2] Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children (vol 52, pg e18, 2011)
    Liu, C.
    Bayer, A.
    Cosgrove, S. E.
    Daum, R. S.
    Fridkin, S. K.
    Gorwitz, R. J.
    CLINICAL INFECTIOUS DISEASES, 2011, 53 (03) : 319 - 319
  • [3] Guidelines for the treatment on infections caused by methicillin-resistant Staphylococcus aureus
    Mensa, J.
    Barberan, J.
    Llinares, P.
    Picazo, J. J.
    Bouza, E.
    Alvarez Lerma, F.
    Borges, M.
    Serrano, R.
    Leon, C.
    Guirao, X.
    Arias, J.
    Carreras, E.
    Sanz, M. A.
    Garcia Rodriguez, J. A.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2008, 21 (04) : 234 - 258
  • [5] Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
    Rybak, Michael J.
    Le, Jennifer
    Lodise, Thomas P.
    Levine, Donald P.
    Bradley, John S.
    Liu, Catherine
    Mueller, Bruce A.
    Pai, Manjunath P.
    Wong-Beringer, Annie
    Rotschafer, John C.
    Rodvold, Keith A.
    Maples, Holly D.
    Lomaestro, Benjamin M.
    PHARMACOTHERAPY, 2020, 40 (04): : 363 - 367
  • [6] Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children
    Kaplan, SL
    Afghani, B
    Lopez, P
    Wu, EB
    Fleishaker, D
    Edge-Padbury, B
    Naberhuis-Stehouwer, S
    Bruss, JB
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (09) : S176 - S183
  • [7] Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
    Rybak, Michael J.
    Le, Jennifer
    Lodise, Thomas
    Levine, Donald
    Bradley, John
    Liu, Catherine
    Mueller, Bruce
    Pai, Manjunath
    Wong-Beringer, Annie
    Rotschafer, John C.
    Rodvold, Keith
    Maples, Holly D.
    Lomaestro, Benjamin M.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 (03) : 281 - 284
  • [8] Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children
    Frank, AL
    Marcinak, JF
    Mangat, PD
    Tjhio, JT
    Kelkar, S
    Schreckenberger, PC
    Quinn, JP
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (06) : 530 - 534
  • [9] Treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in Latin America
    Luna, Carlos M.
    Rodriguez-Noriega, Eduardo
    Bavestrello, Luis
    Gotuzzo, Eduardo
    REVISTA CHILENA DE INFECTOLOGIA, 2010, 27 : S94 - S103
  • [10] Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK
    Gemmell, CG
    Edwards, DI
    Fraise, AP
    Gould, FK
    Ridgway, GL
    Warren, RE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) : 589 - 608